Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Appay

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
JCI Insight|January 23, 2025
Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19Gaëlle Autaa, Laura Papagno, Takuto Nogimori, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2013
CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantationAntoine Roux, Gisèle Mourin, Solène Fastenackels, et al.
The Journal of Experimental Medicine|September 26, 2007
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnoverJorge R Almeida, David A Price, Laura Papagno, et al.
BMC Infectious Diseases|March 20, 2024
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocolMaxime Hentzien, Fabrice Bonnet, Enos Bernasconi, et al.
Ebiomedicine|February 3, 2022
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years oldFrancesco Nicoli, Emmanuel Clave, Kerstin Wanke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2022
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8<sup>+</sup> T Cells in Elderly HumansFrancesco Nicoli, Mariela P Cabral-Piccin, Laura Papagno, et al.
Cell Reports|March 2, 2022
Epitope length variants balance protective immune responses and viral escape in HIV-1 infectionPhillip Pymm, Stefan Tenzer, Edmund Wee, et al.
The Journal of Experimental Medicine|December 15, 2004
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptorTao Dong, Guillaume Stewart-Jones, Nan Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2016
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected ControllersMathieu Angin, Glenn Wong, Laura Papagno, et al.
The Journal of Clinical Investigation|June 5, 2003
Mature CD8(+) T lymphocyte response to viral infection during fetal lifeArnaud Marchant, Victor Appay, Marianne Van Der Sande, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
JCI Insight|January 23, 2025
Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19Gaëlle Autaa, Laura Papagno, Takuto Nogimori, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2013
CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantationAntoine Roux, Gisèle Mourin, Solène Fastenackels, et al.
The Journal of Experimental Medicine|September 26, 2007
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnoverJorge R Almeida, David A Price, Laura Papagno, et al.
BMC Infectious Diseases|March 20, 2024
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocolMaxime Hentzien, Fabrice Bonnet, Enos Bernasconi, et al.
Ebiomedicine|February 3, 2022
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years oldFrancesco Nicoli, Emmanuel Clave, Kerstin Wanke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2022
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8<sup>+</sup> T Cells in Elderly HumansFrancesco Nicoli, Mariela P Cabral-Piccin, Laura Papagno, et al.
Cell Reports|March 2, 2022
Epitope length variants balance protective immune responses and viral escape in HIV-1 infectionPhillip Pymm, Stefan Tenzer, Edmund Wee, et al.
The Journal of Experimental Medicine|December 15, 2004
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptorTao Dong, Guillaume Stewart-Jones, Nan Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2016
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected ControllersMathieu Angin, Glenn Wong, Laura Papagno, et al.
The Journal of Clinical Investigation|June 5, 2003
Mature CD8(+) T lymphocyte response to viral infection during fetal lifeArnaud Marchant, Victor Appay, Marianne Van Der Sande, et al.
Pageof 12